Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Isogawa

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|December 10, 2020
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary EndpointsNaoki Isogawa, Kentaro Takeda, Kazushi Maruo, et al.
Therapeutic Innovation & Regulatory Science|June 10, 2024
Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki IsogawaNaoki Isogawa, Andy Grieve, Ryota Ishii, et al.
Therapeutic Innovation & Regulatory Science|August 2, 2019
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary EndpointsNaoki Isogawa, Kentaro Takeda, Kazushi Maruo, et al.
Therapeutic Innovation & Regulatory Science|May 24, 2024
Performance Evaluation of Interim Analysis in Bioequivalence StudiesNaoki Isogawa, Andy Grieve, Ryota Ishii, et al.
European Journal of Clinical Pharmacology|June 4, 2020
Borrowing external information to improve Bayesian confidence propagation neural networkKeisuke Tada, Kazushi Maruo, Naoki Isogawa, et al.
Nippon Ganka Gakkai Zasshi|October 17, 2014
[Japan phase 3 study of pegaptanib sodium in patients with diabetic macular edema]Tatsuro Ishibashi, Mitsuko Yuzawa, Nagahisa Yoshimura, et al.
Digestive Diseases and Sciences|February 12, 2022
Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel DiseaseMikihiro Fujiya, Tsutomu Kawaguchi, Shoko Arai, et al.
Inflammatory Intestinal Diseases|November 27, 2019
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative ColitisYasuo Suzuki, Mamoru Watanabe, Toshiyuki Matsui, et al.
Pain and Therapy|May 10, 2022
Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 StudiesKenji Miki, Makoto Ohta, Manabu Abe, et al.
Intestinal Research|August 10, 2018
Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studiesSatoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|December 10, 2020
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary EndpointsNaoki Isogawa, Kentaro Takeda, Kazushi Maruo, et al.
Therapeutic Innovation & Regulatory Science|June 10, 2024
Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki IsogawaNaoki Isogawa, Andy Grieve, Ryota Ishii, et al.
Therapeutic Innovation & Regulatory Science|August 2, 2019
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary EndpointsNaoki Isogawa, Kentaro Takeda, Kazushi Maruo, et al.
Therapeutic Innovation & Regulatory Science|May 24, 2024
Performance Evaluation of Interim Analysis in Bioequivalence StudiesNaoki Isogawa, Andy Grieve, Ryota Ishii, et al.
European Journal of Clinical Pharmacology|June 4, 2020
Borrowing external information to improve Bayesian confidence propagation neural networkKeisuke Tada, Kazushi Maruo, Naoki Isogawa, et al.
Nippon Ganka Gakkai Zasshi|October 17, 2014
[Japan phase 3 study of pegaptanib sodium in patients with diabetic macular edema]Tatsuro Ishibashi, Mitsuko Yuzawa, Nagahisa Yoshimura, et al.
Digestive Diseases and Sciences|February 12, 2022
Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel DiseaseMikihiro Fujiya, Tsutomu Kawaguchi, Shoko Arai, et al.
Inflammatory Intestinal Diseases|November 27, 2019
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative ColitisYasuo Suzuki, Mamoru Watanabe, Toshiyuki Matsui, et al.
Pain and Therapy|May 10, 2022
Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 StudiesKenji Miki, Makoto Ohta, Manabu Abe, et al.
Intestinal Research|August 10, 2018
Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studiesSatoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, et al.
Pageof 2